Soleno Therapeutics, Inc. is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases.
We are committed to developing safe and effective therapeutic products that improve the lives of patients living with complex, life-threatening rare diseases with unmet medical needs.
We value team members who want to make a difference. For more information on career opportunities at Soleno, contact email@example.com
Developing novel therapeutics for the treatment of rare diseases.
DCCR ‘Worked Across the Board’ in PWS Trial, But Results Are Less Clear
Soleno Therapeutics Receives Orphan Drug Designation from FDA for Diazoxide Choline for the Treatment of Glycogen Storage Disease Type 1a